Innovative Dual Targeting of the Phosphodiesterase Family and Cyclic GMP Pathway in Heart Failure

JACC Heart Fail. 2024 Jan;12(1):114-116. doi: 10.1016/j.jchf.2023.10.008. Epub 2023 Nov 22.

Author

John C Burnett Jr¹

Affiliation

¹ Cardiorenal Research Laboratory, Department of Cardiovascular Medicine, and Department of Physiology and Biomedical Engineering, Mayo Clinic, Rochester, Minnesota, USA. Electronic address: burnett.john@mayo.edu.

PMID: 37999664
DOI: 10.1016/j.jchf.2023.10.008

No abstract available

Keywords: cGMP; heart failure; phosphodiesterases.

Publication types

Editorial
Research Support, N.I.H., Extramural
Comment

MeSH terms

Cyclic GMP
Heart Failure* / drug therapy
Humans
Phosphoric Diester Hydrolases

Substances

Phosphoric Diester Hydrolases
Cyclic GMP

Grants and funding

R01 HL136340/HL/NHLBI NIH HHS/United States